✦ LIBER ✦

PMS34 COST-UTILITY ANALYSIS OF DENOSUMAB VERSUS RALOXIFENE FOR TREATING OSTEOPOROSIS IN POST-MENOPAUSAL WOMEN IN THE UNITED STATES

✍ Scribed by A.C. Beaubrun; J.B. Daugherty

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS26 Cost-Effectiveness of Denosumab Ve

✍ A. Parthan; M.M. Deflin; N. Yurgin; J. Huang; D.C. Taylor 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMS30 COST-UTILITY ANALYSIS OF DENOSUMAB

✍ J. Cristino; H. Canhão; J. Perelman; C. Santos; J. Pereira 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PMS35 A Cost-Effectiveness Analysis of D

✍ K. Athanasakis; E. Karampli; M. Hollandezos; V. Papagiannopoulou; E. Badamgarav; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PMS36 Cost-Effectiveness of Denosumab fo

✍ J. Lundkvist; M. Löthgren; E. Badamgarav; B. Freyschyss 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB